Embla Genomics ApS — Credit Rating and Financial Key Figures
CVR number: 41685603
Hallinsgade 30, 2100 København Ø
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | -10.01 | -9.21 | -8.26 | |
Wages and salaries | -35.17 | |||
Social security expenses | -0.36 | -0.26 | -0.28 | |
EBIT | - 209.19 | -10.37 | -9.47 | -8.55 |
Other financial income | 0.00 | |||
Other financial expenses | -2.92 | -0.44 | -1.12 | -1.20 |
Pre-tax profit | - 212.12 | -10.81 | -10.59 | -9.75 |
Income taxes | 41.02 | 2.38 | 2.14 | |
Net earnings | - 171.10 | -8.43 | -10.59 | -7.60 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Intangible assets total | ||||
Tangible assets total | ||||
Investments total | ||||
Long term receivables total | ||||
Inventories total | ||||
Current other receivables | 0.24 | 0.21 | 0.21 | 0.08 |
Current deferred tax assets | 41.02 | 43.40 | 43.40 | 45.54 |
Short term receivables total | 41.25 | 43.61 | 43.60 | 45.62 |
Cash and bank deposits | 27.65 | 16.87 | 6.28 | 6.66 |
Cash and cash equivalents | 27.65 | 16.87 | 6.28 | 6.66 |
Balance sheet total (assets) | 68.90 | 60.47 | 49.88 | 52.28 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
Share premium account | 200.00 | 200.00 | 200.00 | |
Other reserves | 200.00 | |||
Retained earnings | - 171.10 | - 179.53 | - 190.12 | |
Profit of the financial year | - 171.10 | -8.43 | -10.59 | -7.60 |
Shareholders equity total | 68.90 | 60.47 | 49.88 | 42.28 |
Non-current owed to group member | 10.00 | |||
Non-current liabilities total | 10.00 | |||
Current liabilities total | ||||
Balance sheet total (liabilities) | 68.90 | 60.47 | 49.88 | 52.28 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.